UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
This comparison highlights fee structures between index and mutual funds, helping you understand long-term cost differences and pick cheaper options.
27,578 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A Biel note argues that biel: salesforce’s transaction data creates a durable moat for Salesforce, tying revenue to a...
Titan America (TTAM) is shaping investor expectations in 2026 as Q1 results roll in. This deep dive translates earnin...
A practical, investor-friendly look at Gambling.com Group's Q1 2026 earnings. This deep dive breaks down revenue driv...
As RMD ages move higher, retirees have a narrow window to shift high-yield dividend holdings into Roth accounts and h...
The race to a cleaner power grid is accelerating. Projected annual global renewable energy investment could reach $2....
Investors woke up to a sharp move in Life360 after a strong Q4 report, but guiding headwinds sparked a sell-off. This...
Palantir Technologies has delivered a staggering 625% rally since 2020, but a mix of government ties and governance s...
A strong first quarter and solid cash generation helped CVS Health's shares spark on Wednesday. This guide breaks dow...
A clear, practical breakdown of DEFT's Q4 2025 results and what the deft 2025 earnings transcript signals for 2026. L...
Toro's Q2 2026 earnings reveal how the company is balancing lawn and turf equipment demand with costs. This analysis ...
Memory demand is reshaping the sector, and Micron sits at the center. This guide explains what drives micron technolo...